Xilio Therapeutics

About Xilio Therapeutics

Xilio Therapeutics is a biotechnology company focused on developing tumor-selective immunotherapies. Their vision is to create a future where immuno-oncology therapies eliminate cancer at its source without severe systemic side effects, using a proprietary platform for tumor-activated biologics.

Products & Services

Vilastobart (anti-CTLA-4):A tumor-selective immunotherapy targeting CTLA-4.

XTX501:A product in the pipeline, specifics not detailed in the content.

Masked T Cell Engagers:Novel immunotherapies designed for tumor-selective activation.

Specialties

Tumor-selective immunotherapy Immuno-oncology Tumor-activated biologics Masked bispecifics Masked T cell engagers

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 50000000 MR: - FA: $50.0 million FAN: 50000000	D: 2025-06-05 FD: 2025-06-05	6 investors
2	RT: Public Offering T: - FT: Public Offering	A: 50000000 MR: - FA: $50.0 Million FAN: 50000000	D: 2025-06-02 FD: 2025-06-02	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 11300000 MR: - FA: approximately $11.3 million FAN: 11300000	D: 2024-03-28 FD: 2024-03-28	2 investors

Public Offering Latest

2025-06-05

$50.0M

6 investors (Pro only)

Public Offering 2025-06-02

$50.0M

Private Placement 2024-03-28

$11.3M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

René Russo

President, Chief Executive Officer and Board Member

U

Uli Bialucha

Chief Scientific Officer

S

Scott Coleman

Chief Development Officer

C

Chris Frankenfield

Chief Financial Officer and Chief Operating Officer

C

Caroline Hensley

Chief Legal Officer

K

Katarina Luptakova

Chief Medical Officer

View 19 more team members with Pro

Unlock Full Team Directory

Recent News